Stay updated on Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.

Latest updates to the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.0.2 and removed the older v3.0.1 entry, the MedlinePlus Genetics 'Melanoma' topic, and the 'Back to Top' link.SummaryDifference0.4%
- Check9 days agoChange DetectedThe web page has been updated to include information on Melanoma under MedlinePlus Genetics topics, and the revision number has changed from v3.0.0 to v3.0.1.SummaryDifference0.4%
- Check16 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new medical topics related to biopsy and melanoma. Notably, the previous version's references to certain genetic diseases and specific antineoplastic agents have been removed.SummaryDifference3%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe webpage has been updated to include detailed information about a clinical trial for neoadjuvant PD-1 blockade in patients with Stage IIB/C melanoma, including study details, eligibility criteria, and contact information for participation.SummaryDifference100%
Stay in the know with updates to Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.